Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution Study.

Nehad M AyoubMona FaresRaya MarjiSamir M Al BashirRami J Yaghan

Published in: Breast cancer (Dove Medical Press) (2021)

Tumor PD-L1 expression was associated with advanced clinicopathologic features and worse prognosis in this cohort of Jordanian breast cancer patients. Future studies are needed to better understand the impact of PD-L1 blockade therapy on treatment outcomes in eligible breast cancer patients in Jordan.

Keyphrases

poor prognosis
current status
stem cells
long non coding rna
case control
bone marrow
cell therapy
smoking cessation
replacement therapy